Relationships between chronic use of statin therapy, presentation of acute coronary syndromes and one-year mortality after an incident acute coronary event

International Journal of Cardiology

Volumn 163, Issue 1, 2013, Pages 102-104

  Vervueren, Paul Louis ^a   Elbaz, Meyer ^a   Dallongeville, Jean ^b   Arveiler, Dominique ^c   Ruidavets, Jean Bernard ^d   Montaye, Michèle ^b   Wagner, Aline ^c   Amouyel, Philippe ^b   Haas, Bernadette ^c   Bongard, Vanina ^d   Ferrières, Jean ^a,d  

^a CHU RANGUEIL   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Acute coronary syndromes; Prognosis; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; FRANCE; HEART ARREST; HUMAN; LETTER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; AGE DISTRIBUTION; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMORBIDITY; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; REGISTER; SHOCK;

EID: 84873080886     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.112     Document Type: Article

References (10)

1. F.M. Sacks, M.A. Pfeffer, and L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
2. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
3. K. Almuti, R. Rimawi, D. Spevack, and R.J. Ostfeld Effects of statins beyond lipid lowering: potential for clinical benefits Int J Cardiol 109 2006 7 15
4. F. Taylor, K. Ward, and T.H. Moore Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev 1 Jan. 2011 CD004816 [19]
5. F.A. Spencer, J. Allegrone, and R.J. Goldberg Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study Ann Intern Med 140 2004 857 866
6. T. Bauer, M. Bohm, and R. Zahn Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction J Cardiovasc Pharmacol 53 2009 132 136
7. A.C. Sposito, and M.J. Chapman Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit Arterioscler Thromb Vasc Biol 22 2002 1524 1534
8. K.H. Yun, M.H. Jeong, and S.K. Oh The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 137 2009 246 251
9. C. Heeschen, C.W. Hamm, and U. Laufs Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452
10. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 49 50